Security Snapshot

Twist Bioscience Corp - Common Stock (TWST) Institutional Ownership

CUSIP: 90184D100

13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

279

Shares (Excl. Options)

77,010,083

Price

$47.52

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+1,868,564
Value change
+$106,141,377
Number of holders
279
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
61,275,791
SEC-reported price per share
$60.94
Insider filing price
$60.94
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TWST - Twist Bioscience Corp - Common Stock is tracked under CUSIP 90184D100.
  • 279 institutions reported positions in Q1 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 242 to 279 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $2,379,251,318 to $3,657,692,202.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 279 institutions filings for Q1 2026.

Open SEC evidence

Security key

90184D100

Latest holder period

Q1 2026

13F holders

279

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
TWST
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 10% -17% $301,406,672 -$57,820,530 6,342,733 -16% ARK Investment Management LLC 31 Mar 2026
Artisan Partners Limited Partnership 10% +6.7% $296,312,372 +$18,444,801 6,217,213 +6.6% Artisan Partners Asset Management Inc. 27 Feb 2026
EdgePoint Investment Group Inc. 8.8% +29% $184,680,211 +$44,493,376 5,377,991 +32% EdgePoint Investment Group Inc. 31 Dec 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 8.6% -11% $264,592,541 -$34,379,339 5,269,718 -11% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 31 Mar 2026
BlackRock, Inc. 8.3% $197,947,718 4,927,750 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 5% $147,402,716 3,101,909 Vanguard Capital Management 31 Mar 2026
STATE STREET CORP 5.1% +20% $86,926,233 +$15,338,157 3,089,063 +21% STATE STREET CORPORATION 30 Sep 2025
Invesco Ltd. 3.9% $91,850,982 2,347,929 Invesco Ltd. 30 Jun 2025

As of 31 Mar 2026, 279 institutional investors reported holding 77,010,083 shares of Twist Bioscience Corp - Common Stock (TWST). This represents 126% of the company’s total 61,275,791 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
97%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Artisan Partners Limited Partnership 10% 6,367,777 +9.2% 0.49% $302,596,753
ARK Investment Management LLC 10% 6,342,733 -16% 2.3% $301,406,681
BlackRock, Inc. 9.1% 5,554,362 -5.8% 0% $263,943,282
EdgePoint Investment Group Inc. 8.8% 5,382,521 +0.08% 2.1% $255,777,398
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 8.6% 5,269,718 -11% 0.83% $250,416,999
STATE STREET CORP 6% 3,670,682 +1.2% 0.01% $174,430,809
VANGUARD PORTFOLIO MANAGEMENT LLC 4.3% 2,649,101 0% 0.01% $125,885,280
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 2,639,044 0% 0% $125,407,371
Invesco Ltd. 3.5% 2,171,898 +68% 0.02% $103,208,593
FMR LLC 3.1% 1,889,945 +2642% 0% $89,810,193
GOLDMAN SACHS GROUP INC 2.8% 1,705,546 +0.53% 0.01% $81,047,546
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,519,713 +4.1% 0% $72,230,837
Amova Asset Management Americas, Inc. 2.4% 1,496,099 -21% 1% $71,094,624
Sumitomo Mitsui Trust Group, Inc. 2.4% 1,496,099 -21% 0.05% $71,094,624
FARALLON CAPITAL MANAGEMENT LLC 2.3% 1,427,650 +18562% 0.44% $67,841,928
Thrivent Financial for Lutherans 2.1% 1,312,544 -3.6% 0.12% $62,373,000
Soleus Capital Management, L.P. 2% 1,226,629 -34% 2.4% $58,289,410
CITADEL ADVISORS LLC 2% 1,220,400 +3708% 0.04% $57,993,408
BAILLIE GIFFORD & CO 2% 1,215,151 -4.8% 0.06% $57,743,975
First Light Asset Management, LLC 1.4% 878,848 -23% 3.7% $41,762,857
Tao Capital Management LP 1.4% 828,815 0% 33% $39,385,289
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.3% 823,976 -30% 0.01% $39,155,339
DIMENSIONAL FUND ADVISORS LP 1.3% 781,618 -4.1% 0.01% $37,128,685
WELLINGTON MANAGEMENT GROUP LLP 1.2% 738,629 -9.2% 0.01% $35,099,650
Balyasny Asset Management L.P. 1.2% 726,288 +25% 0.07% $34,513,206

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Latest
Q1 2026
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 77,010,083 $3,657,692,202 +$106,141,377 $47.52 279
2025 Q4 75,001,500 $2,379,251,318 +$34,609,404 $31.72 242
2025 Q3 73,764,582 $2,075,556,896 +$57,804,960 $28.14 235
2025 Q2 71,133,390 $2,616,814,853 +$58,445,660 $36.79 240
2025 Q1 69,532,083 $2,729,868,536 +$98,718,253 $39.26 260
2024 Q4 66,360,913 $3,083,489,168 +$6,148,856 $46.47 244
2024 Q3 66,073,350 $2,986,931,967 -$9,670,153 $45.18 240
2024 Q2 65,972,475 $3,251,056,592 +$28,344,193 $49.28 256
2024 Q1 67,075,830 $2,301,195,873 +$12,173,886 $34.31 230
2023 Q4 66,744,591 $2,459,763,309 +$20,095,641 $36.86 215
2023 Q3 66,341,769 $1,344,049,066 -$31,879,539 $20.26 191
2023 Q2 68,103,043 $1,393,371,812 +$106,475,508 $20.46 185
2023 Q1 63,810,827 $961,273,962 +$17,347,246 $15.08 197
2022 Q4 62,336,899 $1,484,114,188 +$31,639,333 $23.81 191
2022 Q3 59,850,512 $2,097,211,101 +$44,899,500 $35.24 206
2022 Q2 57,994,411 $2,008,438,723 -$90,076,201 $34.96 188
2022 Q1 54,121,106 $2,662,382,357 +$281,218,717 $49.38 193
2021 Q4 51,230,952 $3,958,124,330 +$152,934,374 $77.39 224
2021 Q3 48,658,857 $5,195,018,312 +$41,898,607 $106.97 229
2021 Q2 48,123,755 $6,401,051,212 +$152,118,907 $133.25 240
2021 Q1 46,988,226 $5,820,040,994 +$482,887,437 $123.86 234
2020 Q4 42,909,917 $6,062,828,297 +$547,775,260 $141.29 215
2020 Q3 39,702,868 $3,018,023,941 +$217,077,489 $75.97 191
2020 Q2 37,011,859 $1,675,114,837 +$285,296,567 $45.30 141
2020 Q1 30,828,177 $943,220,817 +$343,349,207 $30.58 116
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .